AALSS

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 5, Issue SUPPL. 1, 2004, Pages 94-98

  Yen, Albert ^a   Simpson, Ericka ^a   Haverkamp, Lanny ^a   Appel, Stanley ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SOMATOMEDIN C;

ACCURACY; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BREATHING; CLINICAL TRIAL; DIET THERAPY; DISEASE COURSE; FUNCTIONAL ASSESSMENT; HUMAN; LUNG FUNCTION TEST; MUSCLE STRENGTH; OUTCOMES RESEARCH; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RATING SCALE; SCORING SYSTEM; SPEECH; SURVIVAL RATE; SWALLOWING;

EID: 6444235058     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/17434470410019708-65     Document Type: Article

References (3)

1. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987; 22: 328-333.
2. Lai EC, Felice KJ, Festoff BW et al. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo controlled study. The North America ALS/IGF-I Study Group. Neurology 1997: 49: 1621-1630.
3. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995; 118 (Pt 3): 707-719.